MONTGOMERY, Ala.–(BUSINESS WIRE)–Kowa Pharmaceuticals America, Inc. announced today that it has entered into an agreement with Allergan plc. to co-promote Allergan’s BYSTOLIC® (nebivolol), a beta blocker approved for the treatment of hypertension to lower blood pressure, in the United States. Kowa’s nationwide sales force will co-promote BYSTOLIC to cardiologists and select […]